These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1703809)

  • 21. Screening of blood donors for antibody to human immunodeficiency virus type 1.
    Acquaye JK
    West Afr J Med; 1993; 12(2):93-5. PubMed ID: 8398939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HIV study of the German Red Cross of West Germany 1985-1989: prevalence/incidence and mode of infection, retrospective studies].
    Glück D; Kubanek B; Caspari G; Elbert G; Gathof B; Grässmann W; Hesse R; Holzberger G; Koerner K; Richter K
    Beitr Infusionsther; 1990; 26():1-4. PubMed ID: 1703802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HIV infection in legal autopsies].
    Penning R; Tutsch-Bauer E; Beer G; Gürtler L; Spann W
    Beitr Gerichtl Med; 1989; 47():23-9. PubMed ID: 2818484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy and cost-benefit of pooled versus singleton screening blood donations for anti-HIV: impact on different blood bank set-ups.
    Novack L; Pliskin JS; Shinar E; Safi J; Sarov B
    Trop Doct; 2006 Oct; 36(4):236-9. PubMed ID: 17034705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion-associated human immunodeficiency virus type 1 from screened antibody-negative blood donors.
    Roberts CR; Longfield JN; Platte RC; Zielmanski KP; Wages J; Fowler A
    Arch Pathol Lab Med; 1994 Dec; 118(12):1188-92. PubMed ID: 7979912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Retrovirus and blood transfusion].
    Barrera JM; Ercilla MG; Gil BC
    Sangre (Barc); 1993 Jun; 38(3):187-92. PubMed ID: 8105545
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current aspects of HIV infection].
    Gürtler LG
    Beitr Infusionsther; 1991; 28():1-6. PubMed ID: 1725606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk of HIV-1 or 2 infection associated with transfusion in Benin].
    Zohoun A; Lafia E; Houinato D; Anagonou S
    Bull Soc Pathol Exot; 2004 Nov; 97(4):261-4. PubMed ID: 17304747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HIV antigen study].
    Reissigl H; Rosmanith P; Schönitzer D
    Beitr Infusionsther; 1989; 24():14-7. PubMed ID: 2481531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening of donor blood for anti-HIV. Experiences from blood donor screening 1986-1988].
    Schmidt KW; Dickmeiss E
    Ugeskr Laeger; 1990 Sep; 152(36):2552-6. PubMed ID: 2402841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of HIV and hepatitis C co-infection among blood donors in Kathmandu Valley, Nepal.
    Karki S; Ghimire P; Tiwari BR; Shrestha AC; Gautam A; Rajkarnikar M
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):66-70. PubMed ID: 19323036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
    Busch MP; Glynn SA; Stramer SL; Strong DM; Caglioti S; Wright DJ; Pappalardo B; Kleinman SH;
    Transfusion; 2005 Feb; 45(2):254-64. PubMed ID: 15660836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transfusion-associated HIV infection].
    Gürtler LG; Eberle J; Bader L
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():7-10. PubMed ID: 8000258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Donor exclusions, discarded blood and transfusion unsuited blood conserves of 2,13 million potential blood donors 1991 to 1994].
    Diekamp U; Wehrend W; Marklof E; Kamutzky K
    Beitr Infusionsther Transfusionsmed; 1996; 33():81-92. PubMed ID: 8974711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.